The question comes first
Readers stay on the topic they searched for, without geographic redirection or assumptions about local-service eligibility.
Reffaq Cancer Platform publishes evidence-based cancer information and keeps general knowledge separate from local operational services. Your country does not change the topic you came to read.
Readers stay on the topic they searched for, without geographic redirection or assumptions about local-service eligibility.
Reffaq Cancer Magazine explains what evidence supports, where uncertainty remains, and which original sources underpin the answer.
Reffaq is the parent brand; Reffaq Cancer Platform is the current knowledge product, and Reffaq Al-Mutalaa is a functionally separate patient service.